bruin study update: analysis of the mechanisms of resistance to pirtobrutinib in cll
Published 1 year ago • 241 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
2:20
genomic evolution and resistance to pirtobrutinib in cll: insights from the bruin study
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
2:39
updates from the phase i/ii bruin study: pirtobrutinib in cll
-
3:01
updates from the bruin study – long-term safety of pirtobrutinib in r/r mcl
-
1:51
updates on the phase i/ii bruin study and the role of pirtobrutinib in mcl
-
1:35
pirtobrutinib in r/r fl: results from the bruin study
-
1:35
phase i/ii bruin update: efficacy of pirtobrutinib in r/r waldenström's macroglobulinemia
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
52:45
loxo demo with ceo matt chambers in the relevant recruiter show
-
5:17
covid-19: treating cll patients
-
4:38
venice i: venetoclax in r/r cll patients
-
1:18
bruin study cohort update: pirtobrutinib for patients with mcl
-
1:08
phase i/ii bruin study: pirtobrutinib in patients intolerant to a covalent btk inhibitor
-
3:07
bruin study: updated two-year subgroup analysis of pirtobrutinib for btki pre-treated mcl
-
1:55
update on the phase i/ii bruin study
-
2:11
latest updates from the phase i/ii bruin study
-
1:55
genomic evolution of patients with cll who progress on pirtobrutinib in the bruin trial
-
2:08
the promise of pirtobrutinib in the treatment of cll
-
1:24
sequencing of btk inhibitors in cll
-
1:59
updated results from the bruin study: pirtobrutinib in the treatment of mcl
-
2:17
updated analysis of bellwave-001: nemtabrutinib in r/r cll
-
0:55
updated results of the bruin trial: pirtobrutinib in r/r mcl